Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...
Scientists have long sought to understand why some plants are fragrant powerhouses while others remain subtle. Now, a ...
Forget Vertex Pharmaceuticals -- CRISPR Therapeutics is a better buy right now.
UCLA researchers have developed a lipid nanoparticle-based gene-editing approach capable of inserting an entire healthy gene into human airway cells, restoring key biological function in a laboratory ...
The Canadian government's recent approval of the first gene-edited animal to enter the food system has reignited debates over ...
UCLA researchers have developed a lipid nanoparticle-based gene-editing approach capable of inserting an entire healthy gene ...
CRISPR Therapeutics (NASDAQ: CRSP) already has notable achievements under its belt. For instance, it developed Casgevy, a ...
UCLA researchers use lipid nanoparticles to insert full CFTR gene into airway cells, restoring function and opening new ...
Researchers explore gene-editing as a potential one-time solution for high cholesterol, but medication remains essential for now.
Welcome to this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox.
Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time ...